Clinical trial · Observational
Factors Influencing Cancer Patients Participation in Clinical Trials in China.
Assessing Knowledge and Affecting Factors Associated With Cancer Patients Participation in Clinical Trials in China.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The patient related factors and the doctor related factors that influence patient decision regarding participation in a cancer clinical trial will be explored by questionnaire.
- timeFrame
- 1 year
Secondary outcomes (2)
- measure
- Oncology patients' understanding and attitude of clinical trials towards cancer clinical research will be evaluated by questionnaire.
- timeFrame
- 1 year
- measure
- The actual experience of participants in a cancer clinical trial will be investigated by questionnaire.
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of malignancy * Aged 18 years or older * Ability to understand and complete the questionnaire independently or with the help of a relative or staff member of the oncology department * Patients have been consented to join an oncology treatment clinical study and have begun active treatment of an oncology clinical trial Exclusion Criteria: • Not meeting all eligibility criteria
References
Publications (1)
- DERIVEDJiang S, Liu P, Yang S, Yang J, Wu D, Fang H, Qin Y, Zhou S, Xu J, Sun Y, Mo H, Gui L, Xing P, Lan B, Zhang B, Tang L, Sun Y, Shi Y. Evaluating stress, satisfaction and the associated influencing factors of participants in cancer clinical trials: a cross-sectional study in China. BMJ Open. 2019 Jun 1;9(5):e028589. doi: 10.1136/bmjopen-2018-028589. PMID 31154312